Skip to main content

Table 5 Multiple logistic Regression: Factors influencing glycaemic control (N = 591)

From: Profile and factors associated with glycaemic control of patients with type 2 diabetes in Greece: results from the diabetes registry

 

OR

95% CI

p-value

Family history of diabetes

 No

Ref.

  

 Yes

1.53

1.06–2.23

.025

Duration of T2DM

 1–5 years

Ref.

  

 5–10 years

1.10

.66–1.81

.717

  ≥ 10 years

.92

.59–1.43

.721

BMI score

 BMI < 25 (kg/m2)

Ref

  

 BMI 25–30

2.08

1.05–4.13

.035

 BMI > 30

2.14

1.12–4.07

.021

Gender

 Men

Ref.

  

 Women

1.16

.80–1.69

.425

Age

1.00

.99–1.02

.607

HDL levels (mg/dl)

 HDL > 40

Ref.

  

 HDL ≤ 40

2.12

1.44–3.12

< 0.001

LDL levels (mg/dl)

 LDL < 100

Ref.

  

 LDL ≥ 100

1.53

1.06–2.21

.024

Pharmacological treatment

 Oral antidiabetic agents

.85

.51–1.41

.528

 Injectable antidiabetic agents

.50

.24–1.01

.054

 Combination of oral and injectable antidiabetic agents

Ref.

  
  1. In bold if statistically significant at the p < 0.05 or p < 0.001 level
  2. BMI body mass index, HDL high-density lipoprotein, LDL low-density lipoprotein
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us